{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:50:20Z","timestamp":1787626220839,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004770","name":"University of Parma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018353","name":"European Crohn&apos;s and Colitis Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA 18133"],"award-info":[{"award-number":["CA 18133"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114703","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T02:17:30Z","timestamp":1661739450000},"page":"114703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Discovery of small-molecules targeting the CCL20\/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases"],"prefix":"10.1016","volume":"243","author":[{"given":"Maria Grazia","family":"Martina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Allodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Barocelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigilio","family":"Ballabeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Szpakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Chevign\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Piet van Hamburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Davelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lubberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0874-6697","authenticated-orcid":false,"given":"Marco","family":"Radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114703_bib1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1042\/BST20201114","article-title":"Latest update on chemokine receptors as therapeutic targets","volume":"49","author":"Lai","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2022.114703_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejphar.2014.06.060","article-title":"Chemokine receptors as therapeutic targets: why aren't there more drugs?","volume":"746","author":"Solari","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114703_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/imm.13200","article-title":"Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment","volume":"160","author":"Dyer","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.ejmech.2022.114703_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","article-title":"The CC chemokine CCL20 and its receptor CCR6","volume":"14","author":"Schutyser","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejmech.2022.114703_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/bies.201000063","article-title":"An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6\/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease","volume":"32","author":"Comerford","year":"2010","journal-title":"Bioessays"},{"key":"10.1016\/j.ejmech.2022.114703_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2017.10.013","article-title":"CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation","volume":"88","author":"Kulkarni","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejmech.2022.114703_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102846","article-title":"CCR6-CCL20 axis as a therapeutic target for autoimmune diseases","volume":"20","author":"Meitei","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejmech.2022.114703_bib8","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114703_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141710","article-title":"Expression of CCL20 and its corresponding receptor CCR6 is enhanced in active inflammatory bowel disease, and TLR3 mediates CCL20 expression in colonic epithelial cells","volume":"10","author":"Skovdahl","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114703_bib10","doi-asserted-by":"crossref","first-page":"E3257","DOI":"10.3390\/ijms19103257","article-title":"C-C motif ligand 20 (CCL20) and C-C motif chemokine receptor 6 (CCR6) in human peripheral blood mononuclear cells: dysregulated in ulcerative colitis and a potential role for CCL20 in IL-1\u03b2 release","volume":"19","author":"Skovdahl","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114703_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1023\/B:JOCI.0000018066.46279.6b","article-title":"Increased expression of CCL20 in human inflammatory bowel disease","volume":"24","author":"Kaser","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejmech.2022.114703_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2022.114703_bib13","doi-asserted-by":"crossref","first-page":"G1263","DOI":"10.1152\/ajpgi.00409.2006","article-title":"MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice","volume":"292","author":"Katchar","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2022.114703_bib14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/eji.200324347","article-title":"CCR6 has a non-redundant role in the development of inflammatory bowel disease","volume":"33","author":"Varona","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2022.114703_bib15","first-page":"603","article-title":"CCL20 is negatively regulated by TGF-\u03b21 in intestinal epithelial cells and reduced in crohn's disease patients with a successful response to mongersen, a Smad7 antisense oligonucleotide","volume":"11","author":"Marafini","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejmech.2022.114703_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fphar.2017.00400","article-title":"Frontiers in drug Research and development for inflammatory bowel disease","volume":"8","author":"Curr\u00f2","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114703_bib17","article-title":"Target-based small molecule drug discovery towards novel therapeutics for inflammatory bowel diseases","volume":"27","author":"Li","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejmech.2022.114703_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111805","article-title":"Discovery of small-molecule candidates against inflammatory bowel disease","volume":"185","author":"Bai","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114703_bib19","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/j.bmcl.2018.07.042","article-title":"Identification of a novel series of potent and selective CCR6 inhibitors as biological probes","volume":"28","author":"Tawaraishi","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114703_bib20","unstructured":"D. Dairaghi, D. R. Dragoli, J. Kalisiak, C. W. Lange, M. R. Leleti, Y. Li, R. M. Lui, V. R. Mali, V. Malathong, J. P. Powers, H. Tanaka, J. Tan, M. J. Walters, J. Yang, P. Zhang, Ccr6 Compounds, WO2015\/084842."},{"key":"10.1016\/j.ejmech.2022.114703_bib21","unstructured":"C. D. Hein, T. T. Duong, S. Sinha, L. Li, J. H. Nguyen, D. W. Old, R. Burk, V. Viswanath, S. Rao, J. E. Donello, 3,4-disubstituted 3-Cyclobutene-1,2-Diones and Use Thereof, US2019\/0047947."},{"key":"10.1016\/j.ejmech.2022.114703_bib22","unstructured":"J. J. Campbell, K. Ebsworth, A. Krasinski, V. R. Mali, J. Mcmahon, R. Singh, J. Yang, C. Yu, P. Zhang, Methods of Treating Generalized Pustular Psoriasis with an Antagonist of Ccr6 or Cxcr2, WO2019\/136370."},{"key":"10.1016\/j.ejmech.2022.114703_bib23","unstructured":"O. Allemann, E. Caroff, A. Chavanton-Arpel, A. Croxford, F. Hubler, L. Jacob, E. Meyer, S. Richard-Bildstein, Azetidin-3-ylmethanol Derivatives as Ccr6 Receptor Modulators, WO2021\/219849."},{"key":"10.1016\/j.ejmech.2022.114703_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd4366","article-title":"Phenotypic screening in cancer drug discovery - past, present and future","volume":"13","author":"Moffat","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114703_bib25","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1038\/s41467-020-16820-6","article-title":"Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20","volume":"11","author":"Wasilko","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.114703_bib26","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/bph.13509","article-title":"GPCRdb: the G protein-coupled receptor database - an introduction","volume":"173","author":"Munk","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114703_bib27","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.tetlet.2016.02.068","article-title":"A microwave-assisted multicomponent protocol for the synthesis of benzofuran-2-carboxamides","volume":"57","author":"Vincetti","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114703_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1039\/C5MD00462D","article-title":"A multicomponent pharmacophore fragment-decoration approach to identify selective LRRK2-targeting probes","volume":"7","author":"Tassini","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2022.114703_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/qsar.200630101","article-title":"SmiLibv2.0:ajava-based tool for rapid combinatorial library lnumeration","volume":"26","author":"Sch\u00fcller","year":"2007","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.ejmech.2022.114703_bib30","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions","volume":"49","author":"Warren","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114703_bib31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tips.2010.08.006","article-title":"The minor binding pocket: a major player in 7TM receptor activation","volume":"31","author":"Rosenkilde","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2022.114703_bib32","doi-asserted-by":"crossref","first-page":"S641","DOI":"10.1093\/ecco-jcc\/jjx145","article-title":"Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise","volume":"12","author":"Trivedi","year":"2018","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"10.1016\/j.ejmech.2022.114703_bib33","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.gastro.2007.01.008","article-title":"Identification of a chemokine network that recruits FoxP3+ regulatory T cells into chronically inflamed intestine","volume":"132","author":"Kang","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2022.114703_bib34","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/eji.200737370","article-title":"The chemokine receptor CCR6 is an important component of the innate immune response","volume":"37","author":"Wen","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2022.114703_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94821","article-title":"Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice","volume":"2","author":"Robert","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2022.114703_bib36","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/bcp.13286","article-title":"CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6 + cells in an experimental suction blister: CCL20 inhibition selectively prevents CCR6 + T-cell recruitment","volume":"83","author":"Bouma","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114703_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105050","article-title":"Controlling leukocyte trafficking in IBD","volume":"159","author":"Veny","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2022.114703_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental models of inflammatory bowel diseases","volume":"1","author":"Kiesler","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ejmech.2022.114703_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0076-6879(09)05417-2","article-title":"Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation","volume":"461","author":"Cash","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2022.114703_bib40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X","article-title":"MMFF VI. MMFF94s option for energy minimization studies","volume":"20","author":"Halgren","year":"1999","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114703_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1359-6446(05)03692-5","article-title":"Optimizing the use of open-source software applications in drug discovery","volume":"11","author":"Geldenhuys","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.114703_bib42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114703_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114703_bib44","unstructured":"The PyMOL Molecular Graphics System, Version 1.5.0.4 Schr\u00f6dinger, LLC."},{"key":"10.1016\/j.ejmech.2022.114703_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/bs.mcb.2022.03.002","article-title":"Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors","volume":"169","author":"Lu\u00eds","year":"2022","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114703_bib46","article-title":"The extended N-terminal domain confers atypical chemokine receptor properties to CXCR3-B","volume":"13","author":"D'Uonnolo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2022.114703_bib47","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41467-020-16664-0","article-title":"The atypical chemokine receptor ACKR3\/CXCR7 is a broad-spectrum scavenger for opioid peptides","volume":"11","author":"Meyrath","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.114703_bib48","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.RA118.001975","article-title":"Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells","volume":"293","author":"Wan","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114703_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph0555s46","article-title":"Chemically induced mouse models of colitis","author":"Waldner","year":"2009","journal-title":"Curr Protoc Pharmacol. Chapter 5"},{"key":"10.1016\/j.ejmech.2022.114703_bib50","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejmech.2022.114703_bib51","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1172\/JCI117974","article-title":"Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8","volume":"95","author":"Ivey","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2022.114703_bib52","first-page":"258","article-title":"Ischemic preconditioning protects against gut dysfunction and mucosal injury after ischemia\/reperfusion injury","volume":"23","author":"Moore-Olufemi","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.ejmech.2022.114703_bib53","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/JLB.2MA0420-295RRR","article-title":"CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4","volume":"107","author":"Matti","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejmech.2022.114703_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/JLB.2AB0520-275R","article-title":"Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22","volume":"109","author":"Meyrath","year":"2021","journal-title":"J. Leukoc. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422006055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422006055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:03:00Z","timestamp":1777528980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422006055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":54,"alternative-id":["S0223523422006055"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114703","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of small-molecules targeting the CCL20\/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114703"}}